Skip to main content

IntegraGen Raises $9.6M in Second-Round Financing to Support Launch of Two Genetic Tests

NEW YORK, Nov. 17 (GenomeWeb News) - Genetic-test developer IntegraGen said today that it has completed a second round of financing worth $9.6 million to support the commercialization of its predictive tests.

 

IntegraGen said it has so far raised a total of $24 million to support test development and commercialization.

 

The firm said it plans to market a genetic test for autism in 2006, and a type-II diabetes test in 2008, with other tests slated for launch further in the future.

The Scan

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.